Boothbay Fund Management LLC Has $3.36 Million Stake in Humana Inc. (NYSE:HUM)

Boothbay Fund Management LLC lifted its position in Humana Inc. (NYSE:HUM - Free Report) by 196.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,254 shares of the insurance provider's stock after acquiring an additional 8,779 shares during the period. Boothbay Fund Management LLC's holdings in Humana were worth $3,363,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of HUM. Kovitz Investment Group Partners LLC increased its stake in Humana by 87.7% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 7,845 shares of the insurance provider's stock worth $1,990,000 after buying an additional 3,666 shares in the last quarter. Symmetry Investments LP acquired a new position in Humana in the 4th quarter valued at $551,000. T. Rowe Price Investment Management Inc. lifted its holdings in Humana by 11.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,605,771 shares of the insurance provider's stock valued at $407,401,000 after purchasing an additional 160,952 shares in the last quarter. MGO One Seven LLC boosted its stake in Humana by 17.6% during the 4th quarter. MGO One Seven LLC now owns 2,019 shares of the insurance provider's stock worth $512,000 after purchasing an additional 302 shares during the last quarter. Finally, Pinebridge Investments L.P. grew its holdings in shares of Humana by 28.9% during the fourth quarter. Pinebridge Investments L.P. now owns 13,383 shares of the insurance provider's stock worth $3,395,000 after buying an additional 3,000 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analysts Set New Price Targets

HUM has been the topic of several analyst reports. Cantor Fitzgerald reiterated a "neutral" rating and set a $290.00 price target on shares of Humana in a report on Thursday. StockNews.com lowered Humana from a "buy" rating to a "hold" rating in a research report on Thursday. Guggenheim assumed coverage on Humana in a research report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 target price on the stock. JPMorgan Chase & Co. lowered their price target on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Finally, Truist Financial upped their target price on shares of Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research report on Friday, April 11th. Eighteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, Humana currently has an average rating of "Hold" and a consensus target price of $287.76.

Humana Stock Performance

HUM traded up $2.17 during trading on Friday, hitting $258.21. The stock had a trading volume of 1,739,904 shares, compared to its average volume of 1,752,927. The company has a 50 day simple moving average of $266.20 and a 200-day simple moving average of $270.62. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The firm has a market cap of $31.16 billion, a PE ratio of 25.95, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business's revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $7.23 earnings per share. Analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio (DPR) is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.